Josserand V - Search Results

1

Utility of macrophages in an antitumor strategy based on the vectorization of iron oxide nanoparticles.

Dalzon B , Guidetti M , Testemale D , Reymond S , Proux O , Vollaire J , Collin-Faure V , Testard I , Fenel D , Schoehn G , Arnaud J , Carrière M , Josserand V , Rabilloud T , Aude-Garcia C . Dalzon B , et al. Among authors: josserand v. Nanoscale. 2019 May 16;11(19):9341-9352. doi: 10.1039/c8nr03364a. Nanoscale. 2019. PMID: 30950461

2

Targeting CD44 receptor-positive lung tumors using polysaccharide-based nanocarriers: Influence of nanoparticle size and administration route.

Jeannot V, Mazzaferro S, Lavaud J, Vanwonterghem L, Henry M, Arboléas M, Vollaire J, Josserand V, Coll JL, Lecommandoux S, Schatz C, Hurbin A. Jeannot V, et al. Among authors: josserand v. Nanomedicine. 2016 May;12(4):921-932. doi: 10.1016/j.nano.2015.11.018. Epub 2015 Dec 24. Nanomedicine. 2016. PMID: 26724540 Free article.

3

Electrochemotherapy guided by intraoperative fluorescence imaging for the treatment of inoperable peritoneal micro-metastases.

Josserand V, Kéramidas M, Lavaud J, Righini C, Vollaire J, Bellard E, Rols MP, Teissié J, Coll JL, Golzio M. Josserand V, et al. J Control Release. 2016 Jul 10;233:81-7. doi: 10.1016/j.jconrel.2016.05.003. Epub 2016 May 4. J Control Release. 2016. PMID: 27155365

4

Fluorescent peptide biosensor for monitoring CDK4/cyclin D kinase activity in melanoma cell extracts, mouse xenografts and skin biopsies.

Prével C, Pellerano M, González-Vera JA, Henri P, Meunier L, Vollaire J, Josserand V, Morris MC. Prével C, et al. Among authors: josserand v. Biosens Bioelectron. 2016 Nov 15;85:371-380. doi: 10.1016/j.bios.2016.04.050. Epub 2016 Apr 22. Biosens Bioelectron. 2016. PMID: 27203461

5

LIM Kinase Inhibitor Pyr1 Reduces the Growth and Metastatic Load of Breast Cancers.

Prunier C, Josserand V, Vollaire J, Beerling E, Petropoulos C, Destaing O, Montemagno C, Hurbin A, Prudent R, de Koning L, Kapur R, Cohen PA, Albiges-Rizo C, Coll JL, van Rheenen J, Billaud M, Lafanechère L. Prunier C, et al. Among authors: josserand v. Cancer Res. 2016 Jun 15;76(12):3541-52. doi: 10.1158/0008-5472.CAN-15-1864. Epub 2016 May 23. Cancer Res. 2016. PMID: 27216191 Free article.

6

Toxoplasma gondii TgIST co-opts host chromatin repressors dampening STAT1-dependent gene regulation and IFN-γ-mediated host defenses.

Gay G, Braun L, Brenier-Pinchart MP, Vollaire J, Josserand V, Bertini RL, Varesano A, Touquet B, De Bock PJ, Coute Y, Tardieux I, Bougdour A, Hakimi MA. Gay G, et al. Among authors: josserand v. J Exp Med. 2016 Aug 22;213(9):1779-98. doi: 10.1084/jem.20160340. Epub 2016 Aug 8. J Exp Med. 2016. PMID: 27503074 Free PMC article.

7

Targeting tumors with cyclic RGD-conjugated lipid nanoparticles loaded with an IR780 NIR dye: In vitro and in vivo evaluation.

Choi J, Rustique E, Henry M, Guidetti M, Josserand V, Sancey L, Boutet J, Coll JL. Choi J, et al. Among authors: josserand v. Int J Pharm. 2017 Nov 5;532(2):677-685. doi: 10.1016/j.ijpharm.2017.03.007. Epub 2017 Mar 7. Int J Pharm. 2017. PMID: 28279737 Free article.

8

Anti-tumor efficacy of hyaluronan-based nanoparticles for the co-delivery of drugs in lung cancer.

Jeannot V, Gauche C, Mazzaferro S, Couvet M, Vanwonterghem L, Henry M, Didier C, Vollaire J, Josserand V, Coll JL, Schatz C, Lecommandoux S, Hurbin A. Jeannot V, et al. Among authors: josserand v. J Control Release. 2018 Apr 10;275:117-128. doi: 10.1016/j.jconrel.2018.02.024. Epub 2018 Feb 20. J Control Release. 2018. PMID: 29474960

9

The pyrrolopyrimidine colchicine-binding site agent PP-13 reduces the metastatic dissemination of invasive cancer cells in vitro and in vivo.

Gilson P, Couvet M, Vanwonterghem L, Henry M, Vollaire J, Baulin V, Werner M, Orlowska A, Josserand V, Mahuteau-Betzer F, Lafanechère L, Coll JL, Busser B, Hurbin A. Gilson P, et al. Among authors: josserand v. Biochem Pharmacol. 2019 Feb;160:1-13. doi: 10.1016/j.bcp.2018.12.004. Epub 2018 Dec 7. Biochem Pharmacol. 2019. PMID: 30529691

10

The Toxoplasma effector TEEGR promotes parasite persistence by modulating NF-κB signalling via EZH2.

Braun L, Brenier-Pinchart MP, Hammoudi PM, Cannella D, Kieffer-Jaquinod S, Vollaire J, Josserand V, Touquet B, Couté Y, Tardieux I, Bougdour A, Hakimi MA. Braun L, et al. Among authors: josserand v. Nat Microbiol. 2019 Jul;4(7):1208-1220. doi: 10.1038/s41564-019-0431-8. Epub 2019 Apr 29. Nat Microbiol. 2019. PMID: 31036909 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

85 results

Search Page